[{"data": {"name": "Greater patient access to immuno-oncology therapies\u2014what can", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Francesco de Lorenzo", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4342084?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Cancer Intelligence", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.3332/ecancer.2015.ed48", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCheCNncWiGow-CTAASEp8QE5gs-CDN1bg1kMZbLp-CRK7VSVyXjHCJ", "propertyID": "ISCC"}], "datePublished": "2015-02-25"}, "schema": "schema.org", "mediatype": "application/ld+json"}]